Enanta Pharmaceuticals Inc

Ownership Transactions Reported by 15 Insiders

Symbol
ENTA on Nasdaq
Location
4 Kingsbury Avenue, Watertown, MA

Insiders trading volume in the past year

Enanta Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jay R. Luly President and CEO, Director $6.46M -$41.4K -0.64% Dec 6, 2024
Yat Sun Or Chief Scientific Officer $2.98M -$20.9K -0.7% Dec 6, 2024
Nathaniel S. Gardiner Chief Legal Officer $1M Feb 26, 2024
Paul J. Mellett Chief Fin. & Admin Officer $739K -$20.9K -2.75% Dec 6, 2024
Nathalie Adda Sr. VP & Chief Medical Officer $319K Apr 1, 2022
Brendan Luu Chief Business Officer $291K -$18.4K -5.96% Dec 6, 2024
Tara Lynn Kieffer Chief Product Strategy Officer $236K -$108K -31.4% Dec 6, 2024
Scott T. Rottinghaus Chief Medical Officer $144K -$198K -57.8% Dec 6, 2024
Terry Vance Director $52.9K Mar 6, 2024
Yujiro Hata Director Mar 6, 2024
Mark G. Foletta Director Mar 6, 2024
Lesley Russell Director Mar 6, 2024
Kristine Peterson Director Mar 6, 2024
Matthew Paul Kowalsky Chief Legal Officer Nov 27, 2024
L. Carter Bruce Director Mar 6, 2024

Recent Insider Transactions by Companies or Individuals for Enanta Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.